Jiangsu Nhwa Pharmaceutical: Independent financial advisor report on the grant and adjustment of Jiangsu NHWA Pharmaceutical Limited's 2024 Restricted Stock Incentive Plan by Shanghai Rongzheng Enterprise Consulting Services (Group) Co., Ltd.

SZSI · Aug 3

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

恩华药业：上海荣正企业咨询服务（集团）股份有限公司关于江苏恩华药业股份有限公司2024年限制性股票激励计划授予及调整相关事项之独立财务顾问报告

Jiangsu Nhwa Pharmaceutical: Independent financial advisor report on the grant and adjustment of Jiangsu NHWA Pharmaceutical Limited's 2024 Restricted Stock Incentive Plan by Shanghai Rongzheng Enterprise Consulting Services (Group) Co., Ltd.

Risk Disclaimer

Statement